Athletes on a skin-care Mission
This article was originally published in The Rose Sheet
Executive Summary
Mission Product represents an "entirely new [skin-care] category - athlete-tested skin-care products for everyone that's active," according to Nov. 25 release. Ultra-endurance athlete Charlie Engle initially approached skin-care industry veteran Josh Shaw with the concept, which developed into a range of solutions for common problems among athletes, such as "sunscreens that wouldn't stay on and would sting their eyes, moisturizers that left them feeling greasy, and anti-friction products that needed constant re-application." U.S. soccer star Mia Hamm, two-time NBA Most Valuable Player Steve Nash, and pro skateboarder Ryan Sheckler, among other elites from world of sport, have helped design and test Mission products, which aid in competitive preparation, performance and recovery, company says. Starting Mission lineup comprises long-lasting anti-friction cream, no-sweat sunscreen with SPF 30 and anti-aging technology, vitamin lip balm with SPF 20, restorative foot gel, and an after-sun revive gel for post-sun and wind exposure. Cruelty-free products are charged with "natural, high-quality ingredients," vital nutrients and antioxidants. Product also "makes an impact off the field" by supporting charities such as the Steve Nash Foundation and H20 Africa
You may also be interested in...
Sporty Skin-Care Brand Mission Playing New Ballgame: Mass Market
Athlete-engineered Mission Skincare is preparing for a hard launch of its products in mass market doors and will be serving up a prestige skin-care line promoted by tennis star Serena Williams
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.